FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:2527 June 5, 2008 Number 23 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

Edited by Vinod H. Nargund, Derek Raghavan, and Howard M. Sandler. 634 pp., illustrated. London, Springer, 2008. $79.95. ISBN 978-1-84628-387-1.

The treatment of testicular cancer has been described as one of the true success stories of modern medicine. The contemporary management of this cancer is multidisciplinary — incorporating surgery, radiation therapy, and chemotherapy — and often achieves durable success rates of more than 90% regardless of the stage at presentation. This multidisciplinary approach has been widely adopted and is currently used for the treatment of many other types of cancer. Therefore, it is not surprising that Urological Oncology was edited by a urologic surgeon, a medical oncologist, and a radiation oncologist. They exemplify the kind of multidisciplinary team that manages . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.